Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ultrasmedbio.2020.05.012 http://scihub22266oqcxt.onion/10.1016/j.ultrasmedbio.2020.05.012 32591166!7247506!32591166     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ultrasound+Med+Biol 2020 ; 46 (9): 2530-2545 Nephropedia Template TP {{tp|p=32591166|t=2020. A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19 |pdf=|usr=}}{{32591166}} gab.com Text A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19 JO: Ultrasound Med Biol http://www.kidney.de/pget.php?&tw=1&pmid=32591166 #FOAvip A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China, at the end of 2019. Since then more than eight million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiologic diagnosis is reverse transcription-polymerase chain reaction analysis of respiratory-tract specimens, but the test has a high false-negative rate owing to both nasopharyngeal swab sampling error and viral burden. Hence diagnostic imaging has emerged as a fundamental component of current management of COVID-19. Currently, high-resolution computed tomography is the main imaging tool for primary diagnosis and evaluation of disease severity in patients. Lung ultrasound (LUS) imaging has become a safe bedside imaging alternative that does not expose the patient to radiation and minimizes the risk of contamination. Although the number of studies to date is limited, LUS findings have demonstrated high diagnostic sensitivity and accuracy, comparable with those of chest computed tomography scans. In this note we review the current state of the art of LUS in evaluating pulmonary changes induced by COVID-19. The goal is to identify characteristic sonographic findings most suited for the diagnosis of COVID-19 pneumonia infections. Twit Text FOAVip A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19 ????Ultrasound Med Biol http://www.kidney.de/pget.php?&tw=1&pmid=32591166 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32591166 #FOAvip English Wikipedia <ref>{{Cite pmid|32591166}}</ref> A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19 #MMPMID32591166 Sultan LR; Sehgal CM Ultrasound Med Biol 2020[Sep]; 46 (9): 2530-2545 PMID32591166show ga A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China, at the end of 2019. Since then more than eight million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiologic diagnosis is reverse transcription-polymerase chain reaction analysis of respiratory-tract specimens, but the test has a high false-negative rate owing to both nasopharyngeal swab sampling error and viral burden. Hence diagnostic imaging has emerged as a fundamental component of current management of COVID-19. Currently, high-resolution computed tomography is the main imaging tool for primary diagnosis and evaluation of disease severity in patients. Lung ultrasound (LUS) imaging has become a safe bedside imaging alternative that does not expose the patient to radiation and minimizes the risk of contamination. Although the number of studies to date is limited, LUS findings have demonstrated high diagnostic sensitivity and accuracy, comparable with those of chest computed tomography scans. In this note we review the current state of the art of LUS in evaluating pulmonary changes induced by COVID-19. The goal is to identify characteristic sonographic findings most suited for the diagnosis of COVID-19 pneumonia infections. |*Betacoronavirus[MESH] |COVID-19[MESH] |Clinical Protocols[MESH] |Coronavirus Infections/*diagnostic imaging/therapy[MESH] |Humans[MESH] |Lung/*diagnostic imaging[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnostic imaging/therapy[MESH] |SARS-CoV-2[MESH]A Review of Early Experience in Lung Ultrasound in the Diagnosis and M(epmc).pdf DeepDyve Pubget Overpricing